<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04948424</url>
  </required_header>
  <id_info>
    <org_study_id>Anaemia, retrospective</org_study_id>
    <nct_id>NCT04948424</nct_id>
  </id_info>
  <brief_title>A Retrospective Observational Study to Describe Anaemia Management, Burden of Disease and Outcomes in Chinese Patients on Peritoneal Dialysis Using a Clinical Database</brief_title>
  <official_title>A Retrospective Observational Study to Describe Anaemia Management, Burden of Disease and Outcomes in Chinese Patients on Peritoneal Dialysis Using a Clinical Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University First Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective is to describe the epidemiology, health care resource utilisation&#xD;
      (HCRU) and selected clinical outcomes in patients initiating PD by anaemia status in&#xD;
      real-world setting in China.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Anaemia</measure>
    <time_frame>June 1, 2016 to December 1, 2019</time_frame>
    <description>prevalence and incidence based on Hb values</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Healthcare resource utilisation</measure>
    <time_frame>June 1, 2016 to December 1, 2019</time_frame>
    <description>the number and percentage of patients who experienced as all-cause hospitalisations.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Select adverse clinical outcomes</measure>
    <time_frame>June 1, 2016 to December 1, 2019</time_frame>
    <description>modified MACE (all-cause mortality or major cardiovascular events)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hb and ESA dose trajectories in Chinese PD patients with evidence of inflammation (via c-reactive protein [CRP] and highly sensitive CRP) and post-ESA initiation.</measure>
    <time_frame>June 1, 2016 to December 1, 2019</time_frame>
    <description>infalmmation: hsCRP&gt;3mg/L or CRP&gt;8mg/L</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Anemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        This study is primarily descriptive and all patients meeting the inclusion criteria will be&#xD;
        included. We expect to analysis data on approximately 2000 to 2500 peritoneal dialysis&#xD;
        patients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged ≥14 years at the initiation of peritoneal dialysis&#xD;
&#xD;
          -  Patients with CKD with the first treatment/initiation of peritoneal dialysis between 1&#xD;
             June 2016 and 31 December 2017 with up to 2 years of follow-up data.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with missing age or sex information (proportion of missingness to be&#xD;
             assessed)&#xD;
&#xD;
          -  Patients with diagnosis of any cancer (except for non-melanoma skin cancer) within 12&#xD;
             months prior to and inclusive of the baseline date&#xD;
&#xD;
          -  Patients with evidence of active bleeding within 30 days and inclusive of the baseline&#xD;
             date&#xD;
&#xD;
          -  Patients with peritoneal dialysis switched from hemodialysis or renal transplantation&#xD;
             failure&#xD;
&#xD;
          -  Individuals receiving temporary PD (duration &lt; 30 days) because of acute kidney&#xD;
             injury.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 24, 2021</study_first_submitted>
  <study_first_submitted_qc>June 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2021</study_first_posted>
  <last_update_submitted>August 1, 2021</last_update_submitted>
  <last_update_submitted_qc>August 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University First Hospital</investigator_affiliation>
    <investigator_full_name>Dong Jie</investigator_full_name>
    <investigator_title>Clinical Professor in Renal Division，Department of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

